Step by Stepa HemeOncBuddy patient portal

Vincristine

Illustration: Vincristine

Say it: vin-KRIS-teen · Brand names: Vincasar PFS

Vincristine is a chemotherapy medicine that stops cancer cells from dividing.

What it is

Cells need tiny inner tubes to split into two new cells. Vincristine stops these tubes from forming. Without them, the cancer cell cannot divide and dies.

Often used for

How you get it

Vincristine is given only through a vein (IV) in a clinic or hospital. It takes just a few minutes. It is often given once a week or once every few weeks with other medicines. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

Questions to ask

Part of these treatment plans

Side effect guides

Sources

Quick answers

What is Vincristine?
Vincristine is a chemotherapy medicine that stops cancer cells from dividing. Brand names: Vincasar PFS.
What is Vincristine used for?
acute lymphoblastic leukemia; Hodgkin lymphoma; non-Hodgkin lymphoma; some childhood cancers, such as Wilms tumor and neuroblastoma; rhabdomyosarcoma (a soft tissue cancer).
How is Vincristine given?
Vincristine is given only through a vein (IV) in a clinic or hospital. It takes just a few minutes. It is often given once a week or once every few weeks with other medicines. Your schedule may be different.
What are the common side effects of Vincristine?
Numbness, tingling, or weakness in the hands or feet. Constipation. Hair loss. Jaw pain or muscle aches. Feeling tired. Belly cramps.
When should I call my care team while taking Vincristine?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher; No bowel movement for 3 days, or belly pain and swelling; Pain, redness, swelling, or burning where the IV went in; Trouble walking, falling, or weakness in your legs; Trouble seeing, a drooping eyelid, or a hoarse voice; Trouble peeing.
Which chemotherapy plans include Vincristine?
C10403 (CALGB 10403), DA-EPOCH-R, Hyper-CVAD, POMP, R-CHOP, VAC/IE.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.